B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Saracatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Saracatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dasatinib
23 shared targets
tivozanib
24 shared targets
ponatinib
33 shared targets
cediranib
36 shared targets
osi
26 shared targets
golvatinib
24 shared targets
vandetanib
43 shared targets
canertinib
42 shared targets
danusertib
33 shared targets
raf
29 shared targets
Loading evidence profile...

This evidence profile for Saracatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.